Dose-fractionation schedules for radiotherapy of bone metastases

Breast Care

Volumn 5, Issue 5, 2010, Pages 339-344

  Rades, Dirk ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Bone metastases; Bone pain; Metastatic spinal cord compression; Pathological fractures; Radiotherapy

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; DENOSUMAB; PAMIDRONIC ACID; SAMARIUM 153; STRONTIUM 89; ZOLEDRONIC ACID;

BONE METASTASIS; BREAST CANCER; CANCER PAIN; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; EXTERNAL BEAM RADIOTHERAPY; HUMAN; PAIN; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; REVIEW; RISK ASSESSMENT; SPINAL CORD COMPRESSION; TOXICITY;

EID: 78049374470     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000321134     Document Type: Review

References (45)

1. Coleman RE: Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006;12(suppl):6243s-6249s.
2. Coleman RE, Rubens R: The clinical course of bone metastases in breast cancer. Br J Cancer 1987;77:336-340.
3. Bone Pain Trial Working Party: 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain (randomised comparison with a multifraction schedule over 12 months of patient follow-up). Radiother Oncol 1999;52:111-121.
4. Foro Arnalot P, Fontanals AV, Galcerán JC, Lynd F, Latiesas XS, de Dios NR, Castillejo AR, Bassols ML, Galán JL, Conejo IM, López MA: Random-ized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction. Radiother Oncol 2008;89:150-155.
5. Gaze MN, Kelly CG, Kerr GR, Cull A, Cowie VJ, Gregor A, Howard GCW, Rodger A: Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. Radiother Oncol 1997;45:106-116.
6. Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M 3rd, Suh JH, Demas WF, Movsas B, Petersen IA, Konski AA, Cleeland CS, Janjan NA, DeSilvio M: Randomized trial of short-versus long-course radiotherapy for pallia-tion of painful bone metastases. J Natl Cancer Inst 2005;97:798-804.
7. Koswig S, Budach V: Remineralization and pain relief in bone metastases after different radiothera-py fractions (10 times 3 Gy vs. 1 time 8 Gy). A pro-spective study. Strahlenther Onkol 1999;175:500-508.
8. Nielsen OS, Bentzen SM, Sandberg E, Gadeberg CC, Timothy AR: Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol 1998;47:233-240.
9. Niewald M, Tkocz HJ, Abel U, Scheib T, Walter K, Nieder C, Schnabel K, Berberich W, Kubale R, Fuchs M: Rapid course radiation therapy vs. more standard treatment: a randomized trial for bone metastases. Int J Radiat Oncol Biol Phys 1996;36:1085-1089.
10. Rasmusson B, Vejborg I, Jensen AB, Andersson M, Banning AM, Hoffmann T, Pfeiffer P, Nielsen HK, Sjøgren P: Irradiation of bone metastases in breast cancer patients: a randomized study with 1 year follow-up. Radiother Oncol 1995;34:179-184.
11. Roos DE, Turner SL, O'Brien PC, Smith JG, Spry NA, Burmeister BH, Hoskin PJ, Ball DL; Trans-Tasman Radiation Oncology Group, TROG 96.05: Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 2005;75:54-63.
12. Steenland E, Leer JW, van Houwelingen H, Post WJ, van den Hout WB, Kievit J, de Haes H, Martijn H, Oei B, Vonk E, van der Steen-Banasik E, Wiggenraad RG, Hoogenhout J, Wárlám-Rodenhuis C, van Tienhoven G, Wanders R, Pomp J, van Reijn M, van Mierlo I, Rutten E: The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 1999;52:101-109.
13. Tong D, Gillick L, Hendrickson FR: The palliation of symptomatic osseous metastases. Final results of the study by the Radiation Therapy Oncology Group. Cancer 1982;50:893-899.
14. Souchon R, Wenz F, Sedlmayer F, Budach W, Dunst J, Feyer P, Haase W, Harms W, Sautter-Bihl ML, Sauer R: German Society of Radiation Oncology (DEGRO): DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer: bone metastases and metastatic spinal cord compression (MSCC). Strahlenther Onkol 2009;185:417-424.
15. Okawa T, Kita M, Goto M, Nishijima H, Miyaji N: Randomized prospective clinical study of small, large and twice-a-day fraction radiotherapy for painful bone metastases. Radiother Oncol 1988;13:99-104.
16. Price P, Hoskin PJ, Easton D, Austin D, Palmer SG, Yarnold JR: Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radio-ther Oncol 1986;6:247-255.
17. Cole DJ: A randomized trial of a single treatment versus conventional fractionation in the pallia-tive radiotherapy of painful bone metastases. Clin Oncol (R Coll Radiol) 1989;1:59-62.
18. Chow E, Wu JS, Hoskin P, Coia LR, Bentzen SM, Blitzer PH: International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 2002;64:275-280.
19. Wu JS, Wong R, Johnston M, Bezjak A, Whelan T: Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group: Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 2003;55:594-605.
20. Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD: Palliation of metastatic bone pain (single fraction versus multifraction radiotherapy-a sys-tematic review of randomised trials). Clin Oncol 2003;15:345-352.
21. Chow E, Harris K, Fan G, Tsao MN, Sze WM: Palliative radiotherapy trials for bone metastases: a systematic review. J Clin Oncol 2007;25:1423-1436.
22. Jeremic B, Shibamoto Y, Igrutinovic I: Single 4 Gy re-irradiation for painful bone metastases follow-ing single fraction radiotherapy. Radiother Oncol 1999;52:123-127.
23. Mithal N, Needham P, Hoskin, P: Retreatment with radiotherapy for painful bone metastases. Int J Radiat Oncol Biol Phys 1994;29:1011-1014.
24. Chow E, Ling A, Davis L, Panzarella T, Danjoux C: Pain flare following external beam radiother-apy and meaningful change in pain scores in the treatment of bone metastases. Radiother Oncol 2005;75:64-69.
25. Chow E, Loblaw A, Harris K, Doyle M, Goh P, Chiu H, Panzarella T, Tsao M, Barnes EA, Sinclair E, Farhadian M, Danjoux C: Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases-a pilot study. Support Care Cancer 2008;15:643-647.
26. Loblaw DA, Wu JS, Kirkbride P, Panzarella T, Smith K, Aslanidis J, Warde P: Pain flare in pa-tients with bone metastases after palliative radio-therapy-a nested randomized control trial. Sup-port Care Cancer 2007;15:451-455.
27. Van der Linden YM, Dijkstra SP, Vonk EJ, Marijnen CA, Leer JW; Dutch Bone Metastasis Study Group: Prediction of survival in patients with metastases in the spinal column. Results based on a randomized trial of radiotherapy. Cancer 2005;103:320-328.
28. Maranzano E, Latini P, Checcaglini F, Perrucci E, Aristei C, Panizza BM, Ricci S: Radiation therapy of spinal cord compression caused by breast can-cer: report of a prospective trial. Int J Radiat Oncol Biol Phys 1992;24:301-306.
29. Rades D, Stalpers LJ, Veninga T, Schulte R, Hoskin PJ, Obralic N, Bajrovic A, Rudat V, Schwarz R, Hulshof MC, Poortmans P, Schild SE: Evaluation of five radiation schedules and prog-nostic factors for metastatic spinal cord compres-sion. J Clin Oncol 2005;23:3366-3375.
30. Rades D, Veninga T, Stalpers LJA, Schulte R, Hoskin PJ, Poortmans P, Schild SE, Rudat V. Prognostic factors predicting functional outcome, recurrence-free survival, and overall survival after radiotherapy of metastatic spinal cord compression in breast cancer patients. Int J Radiat Oncol Biol Phys 2006;64:182-188. (Pubitemid 41831225)
31. Rades D, Fehlauer F, Schulte R, Veninga T, Stalpers LJ, Basic H, Bajrovic A, Hoskin PJ, Tribius S, Wildfang I, Rudat V, Engenhart-Cabilic R, Karstens JH, Alberti W, Dunst J, Schild SE: Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord com-pression. J Clin Oncol 2006;24:3388-3393.
32. Rades D, Lange M, Veninga T, Stalpers LJ, Bajrovic A, Adamietz IA, Rudat V, Schild SE: Final results of a study comparing short-course and long-course radiotherapy (RT) for local control of metastatic spinal cord compression (MSCC). J Clin Oncol 2009;27(suppl):abstr 9522.
33. Rades D, Dunst J, Schild SE: The first score pre-dicting overall survival in patients with metastatic spinal cord compression. Cancer 2007;112:157-161.
34. Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B: Direct de-compressive surgical resection in the treatment of spinal cord compression caused by metastatic can-cer: a randomised trial. Lancet 2005;366:643-648.
35. Robinson RG, Preston DF, Baxter KG, Dusing RW, Spicer JA: Clinical experience with stron-tium-89 in prostatic and breast cancer patients. Semin Oncol 1993;20:44-48.
36. Serafini AN, Houston SJ, Resche I, Quick DP, Grund FM, Ell PJ, Bertrand A, Ahmann FR, Orihuela E, Reid RH, Lerski RA, Collier BD, McKillop JH, Purnell GL, Pecking AP, Thomas FD, Harrison KA: Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: A double-blind placebo-controlled trial. J Clin Oncol 1998;16:1574-1581.
37. Kraeber-Bodéré F: Treatment of bone metastases of prostate cancer with strontium-89 chloride: effi-cacy in relation to the degree of bone involvement. Eur J Nucl Med 2000;27:1487-1493.
38. Hoskin PJ, Ford HT, Harmer CI: Hemibody ir-radiation (HBI) for metastatic bone pain in two histological distinct groups of patients. Clin Oncol 1989;1:67-69.
39. Salazar OM, Sandhu T, da Motta NW, Escutia MA, Lanzós-Gonzales E, Mouelle-Sone A, Moscol A, Zaharia M, Zaman S: Fractionated half-body ir-radiation (HBI) for the rapid palliation of wide-spread, symptomatic, metastatic bone disease: a randomized phase III trial of the International Atomic Energy Agency (IAEA). Int J Radiat Oncol Biol Phys 2001;50:765-775.
40. Salazar OM, Rubin P, Hendrickson FR, Komaki R, Poulter C, Newall J, Asbell SO, Mohiuddin M, Van Ess J: Single-dose half-body irradiation for pallia-tion of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report. Cancer 1986;58:29-36.
41. Berenson JR, Hillner BE, Kyle RA, Anderson K, Lipton A, Yee GC, Biermann JS; American Soci-ety of Clinical Oncology Bisphosphonates Expert Panel: American Society of Clinical Oncology clini-cal practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol 2002;20:3719-3736.
42. Santini D, Fratto ME, Vincenzi B, Galluzzo S, Tonini G: Zoledronic acid in the management of metastatic bone disease. Expert Opin Biol Ther 2006;6:1333-1348.
43. Rosen LS, Gordon DH, Dugan W Jr, Major P, Eisenberg PD, Provencher L, Kaminski M, Sime-one J, Seaman J, Chen BL, Coleman RE: Zole-dronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion. Cancer 2004;100:36-43.
44. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL: Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg 2004;62:527-534.
45. Body JJ, Lipton A, Gralow J, Steger GG, Gao G, Yeh H, Fizazi K: Effects of denosumab in patients with bone metastases, with and without previ-ous bisphosphonate exposure. J Bone Miner Res 2010;25:440-446.